MIRA INFORM REPORT

 

 

Report No. :

302251

Report Date :

10.01.2015

 

IDENTIFICATION DETAILS

 

Name :

RANBAXY (MALAYSIA) SDN. BHD.

 

 

Registered Office :

Lot 6.05, Kpmg Tower, 8, First Avenue, Bandar Utama, Level 6, 47800 Petaling Jaya, Selangor

 

 

Country :

Malaysia

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

26.08.1982

 

 

Com. Reg. No.:

89186-K

 

 

Legal Form :

Private Limited

 

 

Line of Business :

Manufacture and distribution of pharmaceutical products

 

 

No. of Employee :

250[2015]

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – September 30, 2014

 

Country Name

Previous Rating

(30.06.2014)

Current Rating

(30.09.2014)

Malaysia

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

MALAYSIA ECONOMIC OVERVIEW

 

Malaysia, a middle-income country, has transformed itself since the 1970s from a producer of raw materials into an emerging multi-sector economy. Under current Prime Minister NAJIB, Malaysia is attempting to achieve high-income status by 2020 and to move farther up the value-added production chain by attracting investments in Islamic finance, high technology industries, biotechnology, and services. NAJIB's Economic Transformation Program (ETP) is a series of projects and policy measures intended to accelerate the country's economic growth. The government has also taken steps to liberalize some services sub-sectors. The NAJIB administration also is continuing efforts to boost domestic demand and reduce the economy's dependence on exports. Nevertheless, exports - particularly of electronics, oil and gas, palm oil and rubber - remain a significant driver of the economy. As an oil and gas exporter, Malaysia has profited from higher world energy prices, although the rising cost of domestic gasoline and diesel fuel, combined with sustained budget deficits, has forced Kuala Lumpur to begin to address fiscal shortfalls, through initial reductions in energy and sugar subsidies and the announcement of the 2015 implementation of a 6% goods and services tax. The government is also trying to lessen its dependence on state oil producer Petronas. The oil and gas sector supplies about 32% of government revenue in 2013. Bank Negara Malaysia (central bank) maintains healthy foreign exchange reserves, and a well-developed regulatory regime has limited Malaysia's exposure to riskier financial instruments and the global financial crisis. Nevertheless, Malaysia could be vulnerable to a fall in commodity prices or a general slowdown in global economic activity because exports are a major component of GDP. In order to attract increased investment, NAJIB earlier raised possible revisions to the special economic and social preferences accorded to ethnic Malays under the New Economic Policy of 1970, but retreated in 2013 after he encountered significant opposition from Malay nationalists and other vested interests. In September 2013 NAJIB launched the new Bumiputra Economic Empowerment Program (BEEP), policies that favor and advance the economic condition of ethnic Malays.

 

Source : CIA


 

EXECUTIVE SUMMARY

 

 

REGISTRATION NO.

:

89186-K

COMPANY NAME

:

RANBAXY (MALAYSIA) SDN. BHD.

FORMER NAME

:

N/A

INCORPORATION DATE

:

26/08/1982

COMPANY STATUS

:

EXIST

LEGAL FORM

:

PRIVATE LIMITED

LISTED STATUS

:

NO

REGISTERED ADDRESS

:

LOT 6.05, KPMG TOWER, 8, FIRST AVENUE, BANDAR UTAMA, LEVEL 6, 47800 PETALING JAYA, SELANGOR, MALAYSIA.

BUSINESS ADDRESS

:

WISMA SELANGOR DREDGING SOUTH BLOCK, 5TH FLOOR, 142A, JALAN AMPANG, 50450 KUALA LUMPUR, WILAYAH PERSEKUTUAN, MALAYSIA.

TEL.NO.

:

03-21614181

FAX.NO.

:

03-21627593

WEB SITE

:

WWW.RANBAXY.COM

CONTACT PERSON

:

JEYABALAN THANGARAJAH ( MANAGING DIRECTOR )

INDUSTRY CODE

:

21001

PRINCIPAL ACTIVITY

:

MANUFACTURE AND DISTRIBUTION OF PHARMACEUTICAL PRODUCTS

AUTHORISED CAPITAL

:

MYR 12,000,000.00 DIVIDED INTO
ORDINARY SHARE 12,000,000.00 OF MYR 1.00 EACH.

ISSUED AND PAID UP CAPITAL

:

MYR 8,000,000.00 DIVIDED INTO
ORDINARY SHARES 7,082,800 CASH AND 917,200 OTHERWISE OF MYR 1.00 EACH.

SALES

:

MYR 76,378,000 [2014]

NET WORTH

:

MYR 57,095,000 [2014]

STAFF STRENGTH

:

250 [2015]

BANKER (S)

:

DEUTSCHE BANK (MALAYSIA) BHD

LITIGATION

:

CLEAR

DEFAULTER CHECK

:

CLEAR

FINANCIAL CONDITION

:

LIMITED

PAYMENT

:

GOOD

MANAGEMENT CAPABILITY

:

AVERAGE

COMMERCIAL RISK

:

LOW

CURRENCY EXPOSURE

:

MODERATE

GENERAL REPUTATION

:

SATISFACTORY

INDUSTRY OUTLOOK

:

AVERAGE GROWTH

 

HISTORY / BACKGROUND

 

The Subject is a private limited company and is allowed to have a minimum of one and a maximum of forty-nine shareholders. As a private limited company, the Subject must have at least two directors. A private limited company is a separate legal entity from its shareholders. As a separate legal entity, the Subject is capable of owning assets, entering into contracts, sue or be sued by other companies. The liabilities of the shareholders are to the extent of the equity they have taken up and the creditors cannot claim on shareholders' personal assets even if the Subject is insolvent. The Subject is governed by the Companies Act, 1965 and the company must file its annual returns, together with its financial statements with the Registrar of Companies.

 

The Subject is principally engaged in the (as a / as an) manufacture and distribution of pharmaceutical products.

The Subject is not listed on Bursa Malaysia (Malaysia Stock Exchange).

 

The immediate holding company of the Subject is RANBAXY LABORATORIES LIMITED, a company incorporated in INDIA.

 

The ultimate holding company of the Subject is DAIICHI SANKYO COMPANY LIMITED, a company incorporated in JAPAN.

 

Share Capital History

Date

Authorised Shared Capital

Issue & Paid Up Capital

26/06/2014

MYR 12,000,000.00

MYR 8,000,000.00

09/09/2002

MYR 12,000,000.00

MYR 8,000,000.00

28/07/1999

MYR 10,000,000.00

MYR 5,000,000.00

22/08/1996

MYR 10,000,000.00

MYR 4,507,617.00

16/08/1993

MYR 4,000,000.00

MYR 2,400,000.00

24/05/1993

MYR 4,000,000.00

MYR 2,381,400.00

03/12/1992

MYR 4,000,000.00

MYR 2,331,998.00

05/08/1992

MYR 4,000,000.00

MYR 2,286,854.00

15/06/1992

MYR 4,000,000.00

MYR 2,121,292.00

10/06/1992

MYR 4,000,000.00

MYR 2,071,292.00

31/05/1992

MYR 4,000,000.00

MYR 1,903,173.00

20/04/1992

MYR 4,000,000.00

MYR 1,893,373.00

31/12/1991

MYR 4,000,000.00

MYR 1,837,400.00

12/12/1991

MYR 4,000,000.00

MYR 1,826,200.00

31/10/1991

MYR 4,000,000.00

MYR 1,764,200.00

18/09/1991

MYR 4,000,000.00

MYR 1,671,198.00

10/04/1991

MYR 2,000,000.00

MYR 1,200,000.00

04/03/1991

MYR 2,000,000.00

MYR 1,197,002.00

03/04/1989

MYR 2,000,000.00

MYR 1,189,949.00

20/02/1989

MYR 2,000,000.00

MYR 1,183,074.00

08/12/1988

MYR 2,000,000.00

MYR 1,163,074.00

19/10/1988

MYR 2,000,000.00

MYR 1,120,662.00

28/06/1988

MYR 2,000,000.00

MYR 1,050,662.00

04/03/1988

MYR 2,000,000.00

MYR 1,045,662.00

12/01/1988

MYR 2,000,000.00

MYR 1,025,662.00

27/10/1987

MYR 2,000,000.00

MYR 980,662.00

03/08/1987

MYR 2,000,000.00

MYR 913,662.00

27/06/1987

MYR 2,000,000.00

MYR 541,662.00

26/08/1982

MYR 2.00

MYR 1.00

 

The major shareholder(s) of the Subject are shown as follows :

 

Name

Address

IC/PP/Loc No

Shareholding

(%)

RANBAXY LABORATORIES LTD.

A-41, INDUSTRIAL AREA PHASE VIII-A, SAHIBZADA AJIT SINGH NAGAR, MOHALI, PUNJAB, 160071, INDIA.

3747

3,189,248.00

39.87

RANBAXY (NERTHERLANDS) BV

PRINS BERNHARDPLEIN, 200, AMSTERDAM, 1097JB, NETHERLANDS.

XLZ00209235

2,507,617.00

31.35

STATUS RESOURCES SDN. BHD.

MENARA TUN RAZAK, JALAN RAJA LAUT, TINGKAT 31, 50250 KUALA LUMPUR, WILAYAH PERSEKUTUAN, MALAYSIA.

148518P

666,985.00

8.34

MS. APARAJITHA A/P M. P. KRISHNAN

3, JALAN SUNGAI CHUA, 43000 KAJANG, SELANGOR, MALAYSIA.

740125-14-5734 A2581876

186,000.00

2.33

MS. CHEAH SOO SEE

51, JALAN CHAN CHIN MOOI, TAMAN TITIWANGSA, OFF JALAN PAHANG, 53200 KUALA LUMPUR, WILAYAH PERSEKUTUAN, MALAYSIA.

540120-07-5080 4565454

150,170.00

1.88

AINLI SDN. BHD.

LOT 6.05, KPMG TOWER, 8, FIRST AVENUE, BANDAR UTAMA, LEVEL 6, 47800 PETALING JAYA, SELANGOR, MALAYSIA.

47079W

139,763.00

1.75

DR SATWANT SINGH GILL.

48, JALAN TANJONG, 46000 PETALING JAYA, SELANGOR, MALAYSIA.

330313-10-5201 1863516

132,651.00

1.66

KINOSHITA CORPORATION SDN. BHD.

5, JALAN KOLEJ MELAYU, 33000 KUALA KANGSAR, PERAK, MALAYSIA.

59013D

120,136.00

1.50

DR MOHAMAD HARUN

KLINIK MOHD HARUN, 1962, JALAN DATO' PATI, 15400 KOTA BHARU, KELANTAN, MALAYSIA.

0817831

100,000.00

1.25

DATO' DR MOHD ZAINEE HAJI GHAZALI

POLIKLINIK HIDAYAH, 4B, ARKEB MARA, 71300 REMBAU, NEGERI SEMBILAN, MALAYSIA.

520218-08-6003 4257940

82,872.00

1.04

MS. RASANAYAKI D/O KRISHNARAJA

5735-C, KLEBANG BESAR, 75200 MELAKA, MELAKA, MALAYSIA.

490328-10-5338 1154249

69,679.00

0.87

DR MOHD ISHAK BIN SYED AHMAD

6, JALAN TENGKERA, 75200 MELAKA, MELAKA, MALAYSIA.

690519-08-6113 7074148

57,115.00

0.71

MS. SHAMSUNNISA @ SHAMSUN NAHAR BINTI M.A.ABDUL JABBAR

7383, JALAN LEREH/SPRING 3, TAMAN SPRING GARDEN, 76400 TANJONG KLING, MELAKA, MALAYSIA.

580409-71-5284 5310329

57,115.00

0.71

MS. JAMILAH AKHTAR BINTI ABDUL RAHMAN

1916-E, TAMAN STADIUM, JALAN STADIUM, 05100 ALOR SETAR, KEDAH, MALAYSIA.

540613-02-5806

50,000.00

0.63

DR MRS NIRMALA MENON

11, LORONG SENYUM MATAHARI, COUNTRY HEIGHTS, 43000 KAJANG, SELANGOR, MALAYSIA.

591123-71-5282 5825081

48,054.00

0.60

DATO' DR SAMBANTHANATHAN UNDERWOOD

UNDERWOOD CLINIC, 5, JALAN KOLEJ MELAYU, 33000 KUALA KANGSAR, PERAK, MALAYSIA.

290210-71-5265 3092898

48,054.00

0.60

DR PETER RAVINDRAN RICHARDS A/L JAMES RICHARDS

3, DESA ROS, 43000 KAJANG, SELANGOR, MALAYSIA.

521018-10-5833 4420099

36,041.00

0.45

MS. NATASHA MENON

11, LORONG SENYUM MATAHARI, COUNTRY HEIGHTS, 43000 KAJANG, SELANGOR, MALAYSIA.

850705-14-6044

35,000.00

0.44

DR HAMID ARSHAT

75M, MEDAN SETIA SATU, PLAZA DAMANSARA, BUKIT DAMANSARA, 50490 KUALA LUMPUR, WILAYAH PERSEKUTUAN, MALAYSIA.

450104-01-5177 2776605

31,250.00

0.39

MR. AROKIASUTHENDRA DASS A/L G. N. DASS

KLINIK REDDY KAJANG, 182, JALAN LANGAT 2, TAMAN SRI LANGAT, JALAN REKO, 43000 KAJANG, SELANGOR, MALAYSIA.

460612-07-5335 2659081

30,000.00

0.38

MS. INNIRA @ INDRA D/O M G NAIR

33, JALAN SETIA DUTA, U13/21B, SETIA ECO PARK, 40170 SHAH ALAM, SELANGOR, MALAYSIA.

0591799

24,988.00

0.31

MS. JEYA VATHANA A/P M. SELVARATNAM

18/279, JALAN HUTAN RECREASI, OFF JALAN TUAN HJ SAID, 70100 SEREMBAN, NEGERI SEMBILAN, MALAYSIA.

531118-05-5000

24,027.00

0.30

DATIN DR VIJAYA LAKSHMI PONNIAH

KLIMIK DAN RUMAH BERSALIN PANI & ASSOCIATES, 44, JALAN LABU LAMA (AST), 70200 SEREMBAN, NEGERI SEMBILAN, MALAYSIA.

430602-07-5262 1339345

20,000.00

0.25

MR. SURAJ ASHROFF SHARON BIN MOHAMAD ALI

KLINIK ALI, 34, JALAN GENUANG KAMPUNG, 85000 SEGAMAT, JOHOR, MALAYSIA.

730804-03-5263 A2502798

20,000.00

0.25

EKIM HOLDINGS SDN. BHD.

10, JALAN SS1/24, KAMPUNG TUNKU, 47300 PETALING JAYA, SELANGOR, MALAYSIA.

76415M

16,400.00

0.21

DR MOIZ BIN SIRAJ

KLINIK MOIZ, 32, JALAN NIAGA 1, 81900 KOTA TINGGI, JOHOR, MALAYSIA.

511126-01-5641 4169530

13,439.00

0.17

DR N. K. S. THARMASELAN A/L N. K. SINNADORAI

P. D. SPECIALIST CENTRE, WISMA N. K. S., LOT 855/1, BATU 1/2, JALAN PANTAI, 71000 PORT DICKSON, NEGERI SEMBILAN, MALAYSIA.

490906-10-5437 2909279

12,014.00

0.15

DR VYTHILINGAM A/L PALANIANDY PILLAY

KLINIK RAJ & RAKAN-RAKAN, 778, JALAN SENTUL, 51000 KUALA LUMPUR, WILAYAH PERSEKUTUAN, MALAYSIA.

450508-08-5945 0573204

10,812.00

0.14

PREETHA FERNANDESA/P C. A. J. FERNANDES & PRANESH A. DOMINIC
[ADMINISTRATOR OF DR ROBERT DOMINIC]

1, LORONG 4/48F, 46050 PETALING JAYA, SELANGOR, MALAYSIA.

490728-71-5098 780709-01-5059

10,000.00

0.13

DR ABDULLAH BIN ABDUL RAHMAN

10, LORONG KENARI 4, TAMAN PAROI JAYA, 70300 SEREMBAN, NEGERI SEMBILAN, MALAYSIA.

451013-08-5537 2000735

10,000.00

0.13

DR SHEK DAUD BIN HAMID

42, LEBUH SUNGAI PINANG 1, TINGKAT BAWAH, 11600 PULAU PINANG, PULAU PINANG, MALAYSIA.

540827-07-5279 4672516

10,000.00

0.13

DR M. RAVINDRAN

KELINIK PANTAI, 532/29, TAMAN MEWAH, 1 1/4 MILE, JALAN PANTAI, 71000 PORT DICKSON, NEGERI SEMBILAN, MALAYSIA.

450110-08-5649 1039297

10,000.00

0.13

DR SELVAKUMAR A/L MURUGIAH

LOT 357, BUKIT AMPANG INDAH, 44000 KUALA KUBU BARU, SELANGOR, MALAYSIA.

521205-08-6199 4380974

10,000.00

0.13

DR NAWAWI BIN TAMBY

MESRA GROUP CLINICS, 21, JALAN BALAU, TAMAN MELODIES, 80250 JOHOR BAHRU, JOHOR, MALAYSIA.

451018-04-5091 0857449

10,000.00

0.13

MR. MUHAMAD MAIDEN BIN M. K. M. ABD MAJID

5, JALAN BJ/6A, TAMAN BUKIT JAYA, BUKIT ANTARABANGSA, 68000 AMPANG, SELANGOR, MALAYSIA.

530715-08-5801 4516091

9,000.00

0.11

DR THURAIRAJU A/L S KRISHNA

KELINIK RAJ & RAKAN-RAKAN, 778, JALAN SENTUL, 51000 KUALA LUMPUR, WILAYAH PERSEKUTUAN, MALAYSIA.

460807-08-5541 7962856

9,000.00

0.11

DR VELAYUDHAM A/L LAKSHMANAN

121, JALAN IPOH, 51200 KUALA LUMPUR, WILAYAH PERSEKUTUAN, MALAYSIA.

380310-71-5077 7991204

8,410.00

0.11

MS. ANGELINA SAROJA

7, JALAN 16/144A, TAMAN BUKIT CHERAS, 56000 KUALA LUMPUR, WILAYAH PERSEKUTUAN, MALAYSIA.

2988615

8,410.00

0.11

DATIN DR VIJAYALETCHUMY A/P RAMASAMY

76, TAMAN ZAABA, TAMAN TUN DR ISMAIL 1, 60000 KUALA LUMPUR, WILAYAH PERSEKUTUAN, MALAYSIA.

471010-05-5226 7695177

7,208.00

0.09

DR MOHD SULAIMAN BIN HAMAT

KELINIK MOHD SULAIMAN, 59D, JALAN TOK LAM, 20100 KUALA TERENGGANU, TERENGGANU, MALAYSIA.

4601548

5,996.00

0.07

DR JOSEPH ARUL

90-H, JALAN PERGAM, 08000 SUNGAI PETANI, KEDAH, MALAYSIA.

7746542

5,000.00

0.06

DR MOHD SALLEHIN BIN HJ ABU BAKAR

POLOKLINIK PENAWAR, 15, TAMAN SRI KAMUNTING, JALAN STESYEN, 84000 MUAR, JOHOR, MALAYSIA.

560429-05-5289 4948765

5,000.00

0.06

MS. SANTHA BHASKARA MENON +

BLOCK E, APARTMENT 6, SUNWAY VIVALDI MONT KIARA, 1, JALAN 19/70A, DESA SRI HARTAMAS, 7TH FLOOR, 50400 KUALA LUMPUR, WILAYAH PERSEKUTUAN, MALAYSIA.

371219-71-5258

1,046.00

0.01

DR M. PARAMESWARAN KRISHNAN

KAJANG KLINIK 3, JALAN SUNGAI CHUA, 43000 KAJANG, SELANGOR, MALAYSIA.

4116356

1,500.00

0.02

---------------

------

8,000,000.00

100.00

============

=====

+ Also Director



DIRECTORS

 

DIRECTOR 1

 

Name Of Subject

:

RAJIV GULATI

Address

:

B-3, 1701, UNITECH WORLD SPA, SECTOR-30, GURGAON INDIA, INDIA.

IC / PP No

:

Z2161770

Nationality

:

INDIAN

Date of Appointment

:

18/05/2012

 

DIRECTOR 2

 

Name Of Subject

:

MR. JEYABALAN A/L V. THANGARAJAH

Address

:

727, HAPPY GARDEN, JALAN RIANG 3, 58200 KUALA LUMPUR, WILAYAH PERSEKUTUAN, MALAYSIA.

IC / PP No

:

5955553

New IC No

:

600522-10-6881

Date of Birth

:

22/05/1960

Nationality

:

MALAYSIAN

Date of Appointment

:

04/11/1997

 

DIRECTOR 3

 

Name Of Subject

:

MR. INDRAJIT BANERJEE

Address

:

F-100, EAST OF KAILASH, NEW DELHI, 2ND FLOOR, 110065, INDIA.

IC / PP No

:

Z2067464

Nationality

:

INDIAN

Date of Appointment

:

18/05/2012

 

DIRECTOR 4

 

Name Of Subject

:

ASHWANI KUMAR MALHOTRA

Address

:

FLAT N, 8, MEGHNA AMBUJA, 191 ROAD, 7, WEST MARREDPALLY SECUNDERABAD, ANDHRA PRADESH, 500026, MALAYSIA.

IC / PP No

:

G3636497

Nationality

:

INDIAN

Date of Appointment

:

04/02/2011

 

DIRECTOR 5

 

Name Of Subject

:

MR. ALOK SHUBHKAR KAPOOR

Address

:

A 37-2, 10, MONT KIARA, JALAN KIARA 1, 50480 KUALA LUMPUR, WILAYAH PERSEKUTUAN, MALAYSIA.

IC / PP No

:

Z1862868

Nationality

:

INDIAN

Date of Appointment

:

31/10/2013

 

DIRECTOR 6

 

Name Of Subject

:

DATO' ABDULLAH BIN MOHD YUSOF

Address

:

28, JALAN SETIAMURNI 12, BUKIT DAMANSARA, 50490 KUALA LUMPUR, WILAYAH PERSEKUTUAN, MALAYSIA.

IC / PP No

:

4071934

New IC No

:

390505-01-5627

Date of Birth

:

05/05/1939

Nationality

:

MALAYSIAN

Date of Appointment

:

09/12/1987

Qualification

:

HE GRADUATED FROM THE UNIVERSITY OF SINGAPORE WITH A BACHELOR OF LAWS (HONOURS) DEGREE IN 1968.

Profile

:

HE IS AN ADVOCATE AND SOLICITOR, HAVING HIS OWN LEGAL PRACTISE SINCE 1970.

 

DIRECTOR 7

 

Name Of Subject

:

MS. SANTHA BHASKARA MENON

Address

:

BLOCK E, APARTMENT 6, SUNWAY VIVALDI MONT KIARA, 1, JALAN 19/70A, DESA SRI HARTAMAS, 7TH FLOOR, 50400 KUALA LUMPUR, WILAYAH PERSEKUTUAN, MALAYSIA.

New IC No

:

371219-71-5258

Date of Birth

:

19/12/1937

Nationality

:

MALAYSIAN

Date of Appointment

:

26/08/1982



MANAGEMENT

 

 

1)

Name of Subject

:

ASHWANI KUMAR MALHOTRA

Position

:

EXECUTIVE VICE PRESIDENT

 

2)

Name of Subject

:

JEYABALAN THANGARAJAH

Position

:

MANAGING DIRECTOR

 

3)

Name of Subject

:

INDRAJIT BANERJEE

Position

:

CHIEF FINANCE OFFICER

 

4)

Name of Subject

:

KAMALNATHHAN

Position

:

BUSINESS DEVELOPMENT MANAGER

 

5)

Name of Subject

:

SAPA MOHAN DAS

Position

:

MARKETING DIRECTOR

 

AUDITOR

 

Auditor

:

KPMG

Auditor' Address

:

KPMG TOWER, 8, FIRST AVENUE, BANDAR UTAMA, LEVEL 10, 47800 PETALING JAYA, SELANGOR, MALAYSIA.

 

COMPANY SECRETARIES

 

1)

Company Secretary

:

MS. AMBIKAI A/P BALA SINGHAM

IC / PP No

:

A1008414

New IC No

:

680722-10-5894

Address

:

28, JALAN PUYOH, BATU 3, JALAN IPOH, 51100 KUALA LUMPUR, WILAYAH PERSEKUTUAN, MALAYSIA.

 

BANKING


Banking relations are maintained principally with :

 

1)

Name

:

DEUTSCHE BANK (MALAYSIA) BHD

 

 

ENCUMBRANCE (S)

 

Charge No

Creation Date

Charge Description

Chargee Name

Total Charge

Status

1

17/09/1984

CHARGE OF FIXED DEPOSIT RECEIPT

UNITED ASIAN BANK BHD

MYR 100,000.00

Unsatisfied

2

17/09/1984

CHARGE OF FIXED DEPOSIT RECEIPT

UNITED ASIAN BANK BHD

MYR 65,000.00

Unsatisfied

2 (BK 272/98)

17/09/1984

CHARGE OF FIXED DEPOSIT RECEIPT

UNITED ASIAN BANK BHD

MYR 65,000.00

Unsatisfied

3

08/01/1986

N/A

HONGKONG BANK MALAYSIA BERHAD

-

Satisfied

4

09/03/1987

N/A

HONGKONG BANK MALAYSIA BERHAD

-

Satisfied

5

11/11/1987

N/A

HONGKONG BANK MALAYSIA BERHAD

-

Satisfied

6

17/02/2003

N/A

HSBC BANK MALAYSIA BERHAD

-

Satisfied

7

28/01/2010

A CHARGE ON DEPOSITT

DEUTSCHE BANK (MALAYSIA) BHD

-

Satisfied

 

LITIGATION CHECK AGAINST SUBJECT


* A check has been conducted in our databank against the Subject whether the Subject has been involved in any litigation. Our databank consists of 99% of the wound up companies in Malaysia.


No legal action was found in our databank.


No winding up petition was found in our databank.



DEFAULTER CHECK AGAINST SUBJECT


* We have checked through the Subject in our defaulters' database which comprised of debtors that have been blacklisted by our customers and debtors that have been placed or assigned to us for collection.


No blacklisted record & debt collection case was found in our defaulters' databank.



PAYMENT RECORD

 

 

SOURCES OF RAW MATERIALS:

 

Local

:

YES

Percentage

:

45%

Overseas

:

YES

Percentage

:

55%

Import Countries

:

ASIA



The Subject refused to provide any name of trade/service supplier and we are unable to conduct any trade enquiry. However, from financial historical data we conclude that :

 

OVERALL PAYMENT HABIT

Prompt 0-30 Days

[

]

Good 31-60 Days

[

X

]

Average 61-90 Days

[

]

Fair 91-120 Days

[

]

Poor >120 Days

[

]

 

 

CLIENTELE

 

Local

:

YES

Percentage

:

60%

Domestic Markets

:

MALAYSIA

Overseas

:

YES

Percentage

:

40%

Export Market

:

ASIA

MIDDLE EAST

Credit Term

:

30 - 60 DAYS

Payment Mode

:

CHEQUES
LETTER OF CREDIT (LC)

Type of Customer

:

PHARMACIES,HOSPITALS,DEALERS

 

OPERATIONS

 

Products manufactured

:

PHARMACEUTICAL PRODUCTS

Product Brand Name

:

LESTRIC, INVORIL, CASCOR, XL, HISTAC

Competitor(s)

:

ALPHA BIOLOGICS SDN BHD
APEX HEALTHCARE BHD
CCM DUOPHARMA BIOTECH BHD
SM PHARMACEUTICALS SDN BHD
Y.S.P. INDUSTRIES (M) SDN BHD

Ownership of premises

:

OWNED

Factory / Premises

:

LOT 23, BAKAR ARANG INDUSTRIAL ESTATE, 08000 SUNGAI PETANI, KEDAH, MALAYSIA.
Tel No: 04-4220660
Fax No: 04-4218640

 

Total Number of Employees:

 

YEAR

2015

2014

2013

2012

2011

2010


GROUP

N/A

N/A

N/A

N/A

N/A

N/A

COMPANY

250

200

200

200

200

200

 

Branch

:

NO

Other Information:


The Subject is principally engaged in the (as a / as an) manufacture and distribution of pharmaceutical products.

The Subject's products are for oral use comprising liquid formulations, tablets, capsules and granules for suspension.

The Subject has a major presence in the areas of Cardio vascular, Antibiotic, Pain Management, Gastrointestinal and Food Supplement, Threpentic segments and others.


Numerous products of the Subject are brand leaders in the hospital and general practitioners (GP) markets such as Invoril and others.



RECENT DEVELOPMENT


August 08, 2013


Kuala Lumpur, Malaysia; Gurgaon, India: Ranbaxy Malaysia Sdn Bhd (RMSB) today announced that it has been allocated the site for setting up its Greenfield manufacturing facility in Malaysia. The company signed a ‘letter of offer’ agreement with Kulim Hi Tech Park (KHTP), a wholly owned state agency and industrial park that houses various other leading industries. KHTP is located at Kulim in the state of Kedah, Malaysia.


The Ranbaxy Greenfield facility will be built on an area of around 15 acres with an investment of around US$ 35 million providing employment to over 200 people. This will be Ranbaxy’s second manufacturing plant in Malaysia. Last year in September, the Government of Malaysia gave an approval to RMSB for setting up a Greenfield manufacturing facility in Malaysia as an Entry Point Project (EPP).


The RMSB new facility would manufacture dosage forms including tablets and capsules primarily in the Cardiovascular, Anti Diabetic, Anti-infective and Gastrointestinal segments. Ranbaxy’s total output in Malaysia will be increased from 1 Billion doses/annum to 3 Billion doses/annum when the new facility is fully operational.



CURRENT INVESTIGATION

 

Latest fresh investigations carried out on the Subject indicated that :

 

Telephone Number Provided By Client

:

N/A

Current Telephone Number

:

03-21614181

Match

:

N/A

Address Provided by Client

:

SUNGAI PETANI LOT 23, BAKAR ARANG INDUSTRIAL ESTATE 08000 GUNGA PETANI

Current Address

:

WISMA SELANGOR DREDGING SOUTH BLOCK, 5TH FLOOR, 142A, JALAN AMPANG, 50450 KUALA LUMPUR, WILAYAH PERSEKUTUAN, MALAYSIA.

Match

:

YES

Latest Financial Accounts

:

YES

 

Other Investigations


We contacted one of the staff from the Subject and she provided some information.


The address provided belongs to the Subject's factory.



FINANCIAL ANALYSIS

 

 

Profitability

Return on Shareholder Funds

:

Unfavourable

[

(40.12%)

]

Return on Net Assets

:

Unfavourable

[

(39.43%)

]

The Subject's unfavourable returns on shareholders' funds indicate the management's inefficiency in utilising its assets to generate returns.

Working Capital Control

Stock Ratio

:

Unfavourable

[

147 Days

]

Debtor Ratio

:

Unfavourable

[

177 Days

]

Creditors Ratio

:

Favourable

[

17 Days

]

The Subject could be incurring higher holding cost. As its capital was tied up in stocks, it could face liquidity problems. The Subject's debtors ratio was high. The Subject should tighten its credit control and improve its collection period. The Subject had a favourable creditors' ratio where the Subject could be taking advantage of the cash discounts and also wanting to maintain goodwill with its creditors.

Liquidity

Liquid Ratio

:

Unfavourable

[

0.79 Times

]

Current Ratio

:

Unfavourable

[

1.33 Times

]

A low liquid ratio means that the Subject may be facing working capital deficiency. If the Subject cannot obtain additional financing or injection of fresh capital, it may face difficulties in meeting its short term obligations.

Solvency

Interest Cover

:

Unfavourable

[

(10.60 Times)

]

Gearing Ratio

:

Favourable

[

0.46 Times

]

The Subject incurred losses in the year. It did not generate sufficient income to service its interest.  If the situation does not improve, the Subject may be vulnerable to default in servicing the interest. The Subject was lowly geared thus it had a low financial risk. The Subject was mainly financed by its shareholders' funds and internally generated funds. In times of economic slowdown / downturn, the Subject being a lowly geared company, will be able to compete better than those companies which are highly geared in the same industry.

Overall Assessment :

Due to its weak liquidity position, the Subject will be faced with problems in meeting all its short term obligations if no short term loan is obtained or additional capital injected into the Subject. The Subject's interest cover was negative, indicating that it did not generate sufficient income to service its interest. If its result does not show impressive improvements or succeed obtaining short term financing or capital injection, it may not be able to service its interest and repay the loans. The Subject as a lowly geared company, will be more secured compared to those highly geared companies. It has the ability to meet all its long term obligations.

Overall financial condition of the Subject : LIMITED

 

 

 

 

MALAYSIA ECONOMIC / INDUSTRY OUTLOOK

 

Major Economic Indicators:

2011

2012

2013

2014*

2015**

Population ( Million)

28.7

29.3

29.8

30.3

30.5

Gross Domestic Products ( % )

5.1

5.6

5.3

6.0

6.0

Domestic Demand ( % )

8.2

9.4

5.6

6.4

6.2

Private Expenditure ( % )

8.2

8.0

8.6

7.9

6.9

Consumption ( % )

7.1

1.0

5.7

6.5

5.6

Investment ( % )

12.2

11.7

13.3

12.0

10.7

Public Expenditure ( % )

8.4

13.3

4.4

2.3

4.2

Consumption ( % )

16.1

11.3

(1.2)

2.1

3.8

Investment ( % )

(0.3)

15.9

4.2

2.6

4.7

Balance of Trade ( MYR Million )

116,058

106,300

71,298

52,314

-

Government Finance ( MYR Million )

(45,511)

(42,297)

(39,993)

(37,291)

-

Government Finance to GDP / Fiscal Deficit ( % )

(5.4)

(4.5)

(4.0)

(3.5)

(3.0)

Inflation ( % Change in Composite CPI)

3.1

1.6

2.5

3.3

4.0

Unemployment Rate

3.3

3.2

3.0

3.0

3.0

Net International Reserves ( MYR Billion )

415

427

-

417

-

Average Risk-Weighted Capital Adequacy Ratio ( % )

3.50

2.20

-

-

-

Average 3 Months of Non-performing Loans ( % )

14.80

14.70

-

-

-

Average Base Lending Rate ( % )

6.60

6.53

6.53

-

-

Business Loans Disbursed( % )

15.3

32.2

-

-

-

Foreign Investment ( MYR Million )

23,546.1

26,230.4

38,238.0

-

-

Consumer Loans ( % )

-

-

-

-

-

Registration of New Companies ( No. )

45,455

45,441

46,321

-

-

Registration of New Companies ( % )

3.0

(0.0)

1.9

-

-

Liquidation of Companies ( No. )

132,485

17,092

26,430

-

-

Liquidation of Companies ( % )

417.8

(87.1)

54.6

-

-

Registration of New Business ( No. )

284,598

324,761

329,895

-

-

Registration of New Business ( % )

5.0

14.0

2.0

-

-

Business Dissolved ( No. )

20,121

20,380

18,161

-

-

Business Dissolved ( % )

1.9

1.3

(10.9)

-

-

Sales of New Passenger Cars (' 000 Unit )

535.1

552.2

576.7

598.4

610.3

Cellular Phone Subscribers ( Million )

35.3

38.5

43.0

43.8

-

Tourist Arrival ( Million Persons )

24.7

25.0

25.7

28.0

-

Hotel Occupancy Rate ( % )

60.6

62.4

62.6

-

-

Credit Cards Spending ( % )

15.6

12.6

-

-

-

Bad Cheque Offenders (No.)

32,627

26,982

28,876

-

-

Individual Bankruptcy ( No.)

19,167

19,575

21,984

-

-

Individual Bankruptcy ( % )

5.8

2.1

12.3

-

-



INDUSTRIES ( % of Growth ):

2011

2012

2013

2014*

2015**

Agriculture

5.8

1.0

2.1

3.8

3.1

Palm Oil

10.8

(0.3)

2.6

6.7

-

Rubber

6.1

(7.9)

(10.1)

(10.4)

-

Forestry & Logging

(7.6)

(4.5)

(7.8)

(4.2)

-

Fishing

2.1

4.3

1.6

2.7

-

Other Agriculture

7.1

6.4

8.2

6.2

-

Industry Non-Performing Loans ( MYR Million )

634.1

-

-

-

-

% of Industry Non-Performing Loans

3.2

-

-

-

-

Mining

(5.4)

1.4

0.9

(0.8)

2.8

Oil & Gas

(1.7)

-

-

-

-

Other Mining

-

-

-

-

-

Industry Non-performing Loans ( MYR Million )

46.5

-

-

-

-

% of Industry Non-performing Loans

0.1

-

-

-

-

Manufacturing #

4.7

4.8

3.4

6.6

5.5

Exported-oriented Industries

4.1

6.5

3.3

5.6

-

Electrical & Electronics

(4.0)

12.7

6.9

13.3

-

Rubber Products

20.7

3.0

11.7

(0.3)

-

Wood Products

(5.1)

8.7

(2.7)

5.1

-

Textiles & Apparel

13.2

(7.1)

(2.6)

11.5

-

Domestic-oriented Industries

10.7

1.7

6.8

9.4

-

Food, Beverages & Tobacco

4.80

2.70

3.60

6.13

6.13

Chemical & Chemical Products

10.0

10.8

5.6

-

-

Plastic Products

3.8

-

-

-

-

Iron & Steel

2.2

(6.6)

5.0

0.1

-

Fabricated Metal Products

21.8

13.8

9.9

2.9

-

Non-metallic Mineral

12.1

2.9

(2.0)

5.4

-

Transport Equipment

12.0

3.4

13.8

22.9

-

Paper & Paper Products

9.5

3.1

1.8

4.7

-

Crude Oil Refineries

9.3

-

-

-

-

Industry Non-Performing Loans ( MYR Million )

6,537.2

-

-

-

-

% of Industry Non-Performing Loans

25.7

-

-

-

-

Construction

4.7

18.6

10.9

12.7

10.7

Industry Non-Performing Loans ( MYR Million )

3,856.9

-

-

-

-

% of Industry Non-Performing Loans

10.2

-

-

-

-

Services

7.1

6.4

5.9

5.9

5.6

Electric, Gas & Water

3.5

4.4

4.2

3.6

3.9

Transport, Storage & Communication

6.50

7.10

7.30

7.50

7.15

Wholesale, Retail, Hotel & Restaurant

5.2

4.7

5.9

6.9

6.5

Finance, Insurance & Real Estate

6.90

9.70

3.70

4.65

4.25

Government Services

12.4

9.4

8.3

6.1

5.6

Other Services

5.1

3.9

5.1

4.8

4.5

Industry Non-Performing Loans ( MYR Million )

6,825.2

-

-

-

-

% of Industry Non-Performing Loans

23.4

-

-

-

-

* Estimate / Preliminary

** Forecast

# Based On Manufacturing Production Index



INDUSTRY ANALYSIS

 

MSIC CODE

21001 : Manufacture of medicinal active substances to be used for their pharmacological properties in the manufacture of medicaments

INDUSTRY :

MANUFACTURING

The manufacturing sector is expected to grow by 5.5% in 2015. It will be bolstered by strong domestic and export-oriented industries in line with growing investment activities and favorable external demand. Moreover, in 2014, the manufacturing sectors have spearheading growth. The manufacturing sector is estimated to grow at a faster pace in 2014 on higher exports of electronics and electrical (E&E) products as external demand improves.

The manufacturing sector expanded strongly during the first half of 2014, the highest growth in three years, spurred by higher global semiconductor sales. Value-added of the manufacturing sector expanded 7.1% during the first half of 2014. Production of the sector rose 6.6% in the first seven months of 2014 supported by resilient domestic demand and recovery in the external sector during the first seven months of the years. The sales value of manufactured products rebounded by 7.7% in the first seven months of 2014. The strong performance of the sector was on account of higher output at 9.4% from the domestic-oriented industries, particularly transport equipment, food and beverage.

The manufacturing sector continued to attract domestic and foreign investment with investment approved by Malaysian Investment Development Authority (MIDA) totaling RM47.4 billion during the first six months of 2014, mainly from Japan, China and Germany. Meanwhile, the capacity utilization rate remained steady at 80.4% during the second quarter of 2014 while average wage per employee and productivity improved to RM2,772 per month and 5.9%, respectively during the first seven months of 2014. Boosted by favorable domestic economic activity and recovery in the external sector, the manufacturing sector is expected to record a better performance with growth of 6.4% in 2014.

In the meantime, production of wood products rebounded by 5.1% largely supported by higher output in the saw-milling and planning of wood segment at 25.9% during the first seven months of 2014. The positive performance was attributed to vibrant residential and commercial construction activities which contributed to increased use of timber frame and glued laminated timber for cost savings compared to the use of concrete and steel. Increased demand from major export destination such as the US, Japan and Australia for Malaysian made furniture contributed to the higher output, particularly wooden and cane furniture which rebounded by 2.2%.

Production of rubber products contracted 0.3% in the first seven months of 2014 on account of slower demand for rubber gloves and rubber tyres. The decline in rubber tyres for vehicles was due to the weaker external demand from the automotive industry, particularly from China. Output of other rubber products contracted 3.8% following the product shift from rubber-based to plastics, silicones and metal alloys in the manufacture of medical devices.

Besides, exports of manufactured products are expected to grow 6.1% in 2014 boosted by the growing demand from advanced economies. However, during the first seven months of 2014, manufactured exports surged 11.4%. The robust growth was buoyed by strengthening demand in the US and EU, reflecting significant exposure of Malaysian exports to the economic performance in the advance economies. The strength in export was broad-based with robust growth in both E&E and non- E&E subsectors.

Under budget 2015, the Government will provide incentive in the form of capital allowance on automation expenditure to encourage automation in the manufacturing sector, which may help in the manufacturing sector.

OVERALL INDUSTRY OUTLOOK : Average Growth



CREDIT RISK EVALUATION & RECOMMENDATION

 


Incorporated in 1982, the Subject is a Private Limited company, focusing on manufacture and distribution of pharmaceutical products. The Subject has been in business for over two decades. It has built up a strong clientele base and satisfactory reputation will enable the Subject to further enhance its business in the near term. The Subject is expected to enjoy a stable market shares. A paid up capital of MYR 8,000,000 allows the Subject to expand its business more comfortably. Having strong support from its holding company has enabled the Subject to remain competitive despite the challenging business environment.


Over the years, the Subject has established an extensive clientele base in the market. Besides catering to the local market, the Subject has penetrated into other countries. With the contribution of both local and overseas customers, the Subject is likely to be exposed to lower commercial risk. Hence, we believe that the Subject has better business expansion opportunities in the future. The Subject is a fairly large and rapidly growing company with over 250 staff in its operations Overall, we regard that the Subject's management capability is average. This indicates that the Subject has greater potential to improve its business performance and raising income for the Subject.

The Subject has generated its turnover of MYR 76,378,000 and its pre-tax loss of MYR -24,639,000. The Subject has generated an unfavourable return on shareholders' funds indicating that the management was inefficient in utilising its funds to generate return. Due to its weak liquidity position, the Subject may face working capital deficiency in meeting its short term financial obligations if no fresh capital are injected into the Subject. Being a lowly geared company, the Subject is exposed to low financial risk as it is mainly dependent on its internal funds to finance its business needs. Given a positive net worth standing at MYR 57,095,000, the Subject should be able to maintain its business in the near terms.



Having a strong assets backing, the Subject possesses latent assets as collateral for further financial extension. Hence, it has good chance of getting loans if the needs arises. The Subject's supplier are from both the local and overseas countries. This will eliminates the risk of dependency on deliveries from a number of key suppliers and insufficient quantities of its raw materials. Overall the Subject has a good control over its resources.


Overall, the Subject's payment habit is good as the Subject has a good credit control and it could be taking advantage of the cash discounts while maintaining a good reputation with its creditors.


The industry shows an upward trend and this trend is very likely to sustain in the near terms. Hence, the Subject is expected to benefit from the favourable outlook of the industry.


Based on the above condition, we recommend credit be granted to the Subject normally.

 

 

 

PROFIT AND LOSS ACCOUNT

 

 

THE FINANCIAL STATEMENTS WERE PREPARED IN ACCORDANCE WITH MALAYSIAN FINANCIAL REPORTING STANDARDS(FRS)

RANBAXY (MALAYSIA) SDN. BHD.

 

Financial Year End

2014-03-31

2012-12-31

2011-12-31

2010-12-31

2009-12-31

Months

15

12

12

12

12

Consolidated Account

Company

Company

Company

Company

Company

Audited Account

YES

YES

YES

YES

YES

Unqualified Auditor's Report (Clean Opinion)

YES

YES

YES

YES

YES

Financial Type

FULL

FULL

FULL

FULL

FULL

Currency

MYR

MYR

MYR

MYR

MYR

TURNOVER

76,378,000

92,991,000

86,726,000

92,728,000

109,056,000

----------------

----------------

----------------

----------------

----------------

Total Turnover

76,378,000

92,991,000

86,726,000

92,728,000

109,056,000

Costs of Goods Sold

(71,870,000)

(61,640,000)

(58,185,000)

(56,765,000)

-

----------------

----------------

----------------

----------------

----------------

Gross Profit

4,508,000

31,351,000

28,541,000

35,963,000

-

----------------

----------------

----------------

----------------

----------------

PROFIT/(LOSS) FROM OPERATIONS

(24,639,000)

8,575,000

7,357,000

17,087,000

16,314,000

----------------

----------------

----------------

----------------

----------------

PROFIT/(LOSS) BEFORE TAXATION

(24,639,000)

8,575,000

7,357,000

17,087,000

16,314,000

Taxation

1,733,000

(1,755,000)

(1,339,000)

(4,222,000)

(3,658,000)

----------------

----------------

----------------

----------------

----------------

PROFIT/(LOSS) AFTER TAXATION

(22,906,000)

6,820,000

6,018,000

12,865,000

12,656,000

----------------

----------------

----------------

----------------

----------------

RETAINED PROFIT/(LOSS) BROUGHT FORWARD

As previously reported

72,501,000

66,481,000

61,823,000

50,558,000

38,862,000

----------------

----------------

----------------

----------------

----------------

As restated

72,501,000

66,481,000

61,823,000

50,558,000

38,862,000

----------------

----------------

----------------

----------------

----------------

PROFIT AVAILABLE FOR APPROPRIATIONS

49,595,000

73,301,000

67,841,000

63,423,000

51,518,000

DIVIDENDS - Ordinary (paid & proposed)

(800,000)

(800,000)

(1,360,000)

(1,600,000)

(960,000)

----------------

----------------

----------------

----------------

----------------

RETAINED PROFIT/(LOSS) CARRIED FORWARD

48,795,000

72,501,000

66,481,000

61,823,000

50,558,000

=============

=============

=============

=============

=============

INTEREST EXPENSE (as per notes to P&L)

Bank overdraft

2,124,000

1,138,000

767,000

567,000

1,075,000

Bankers' acceptance

-

-

-

68,000

-

Revolving loans

-

-

-

-

89,000

Others

-

-

-

-

126,000

----------------

----------------

----------------

----------------

----------------

2,124,000

1,138,000

767,000

635,000

1,290,000

=============

=============

=============

=============

=============

 

 

 

 

BALANCE SHEET

 

 

RANBAXY (MALAYSIA) SDN. BHD.

 

ASSETS EMPLOYED:

FIXED ASSETS

38,094,000

33,872,000

25,093,000

23,037,000

23,001,000

----------------

----------------

----------------

----------------

----------------

TOTAL LONG TERM ASSETS

38,094,000

33,872,000

25,093,000

23,037,000

23,001,000

Stocks

30,671,000

27,585,000

30,950,000

24,062,000

27,857,000

Trade debtors

37,133,000

51,920,000

47,492,000

42,479,000

40,364,000

Other debtors, deposits & prepayments

3,403,000

2,142,000

4,003,000

3,024,000

2,256,000

Amount due from holding company

3,438,000

4,952,000

2,921,000

1,472,000

1,908,000

Cash & bank balances

411,000

127,000

466,000

341,000

1,443,000

Others

703,000

372,000

281,000

111,000

-

----------------

----------------

----------------

----------------

----------------

TOTAL CURRENT ASSETS

75,759,000

87,098,000

86,113,000

71,489,000

73,828,000

----------------

----------------

----------------

----------------

----------------

TOTAL ASSET

113,853,000

120,970,000

111,206,000

94,526,000

96,829,000

=============

=============

=============

=============

=============

CURRENT LIABILITIES

Trade creditors

3,348,000

7,152,000

5,630,000

5,036,000

6,063,000

Other creditors & accruals

6,187,000

4,449,000

4,624,000

2,338,000

7,304,000

Bank overdraft

26,142,000

13,175,000

11,568,000

12,162,000

-

Bill & acceptances payable

-

-

-

1,735,000

2,301,000

Amounts owing to holding company

20,422,000

13,937,000

13,396,000

1,097,000

10,686,000

Amounts owing to related companies

-

-

-

-

8,993,000

Provision for taxation

-

-

-

-

1,857,000

Other liabilities

659,000

145,000

75,000

693,000

640,000

----------------

----------------

----------------

----------------

----------------

TOTAL CURRENT LIABILITIES

56,758,000

38,858,000

35,293,000

23,061,000

37,844,000

----------------

----------------

----------------

----------------

----------------

NET CURRENT ASSETS/(LIABILITIES)

19,001,000

48,240,000

50,820,000

48,428,000

35,984,000

----------------

----------------

----------------

----------------

----------------

TOTAL NET ASSETS

57,095,000

82,112,000

75,913,000

71,465,000

58,985,000

=============

=============

=============

=============

=============

SHARE CAPITAL

Ordinary share capital

8,000,000

8,000,000

8,000,000

8,000,000

8,000,000

----------------

----------------

----------------

----------------

----------------

TOTAL SHARE CAPITAL

8,000,000

8,000,000

8,000,000

8,000,000

8,000,000

RESERVES

Share premium

300,000

300,000

300,000

300,000

300,000

Retained profit/(loss) carried forward

48,795,000

72,501,000

66,481,000

61,823,000

50,558,000

----------------

----------------

----------------

----------------

----------------

TOTAL RESERVES

49,095,000

72,801,000

66,781,000

62,123,000

50,858,000

----------------

----------------

----------------

----------------

----------------

SHAREHOLDERS' FUNDS/EQUITY

57,095,000

80,801,000

74,781,000

70,123,000

58,858,000

Deferred taxation

-

1,311,000

1,132,000

1,342,000

127,000

----------------

----------------

----------------

----------------

----------------

TOTAL LONG TERM LIABILITIES

-

1,311,000

1,132,000

1,342,000

127,000

----------------

----------------

----------------

----------------

----------------

57,095,000

82,112,000

75,913,000

71,465,000

58,985,000

=============

=============

=============

=============

=============

 

 

 

 

FINANCIAL RATIO

 

 

RANBAXY (MALAYSIA) SDN. BHD.

 

TYPES OF FUNDS

Cash

411,000

127,000

466,000

341,000

1,443,000

Net Liquid Funds

(25,731,000)

(13,048,000)

(11,102,000)

(13,556,000)

(858,000)

Net Liquid Assets

(11,670,000)

20,655,000

19,870,000

24,366,000

8,127,000

Net Current Assets/(Liabilities)

19,001,000

48,240,000

50,820,000

48,428,000

35,984,000

Net Tangible Assets

57,095,000

82,112,000

75,913,000

71,465,000

58,985,000

Net Monetary Assets

(11,670,000)

19,344,000

18,738,000

23,024,000

8,000,000

BALANCE SHEET ITEMS

Total Borrowings

26,142,000

13,175,000

11,568,000

13,897,000

2,390,000

Total Liabilities

56,758,000

40,169,000

36,425,000

24,403,000

37,971,000

Total Assets

113,853,000

120,970,000

111,206,000

94,526,000

96,829,000

Net Assets

57,095,000

82,112,000

75,913,000

71,465,000

58,985,000

Net Assets Backing

57,095,000

80,801,000

74,781,000

70,123,000

58,858,000

Shareholders' Funds

57,095,000

80,801,000

74,781,000

70,123,000

58,858,000

Total Share Capital

8,000,000

8,000,000

8,000,000

8,000,000

8,000,000

Total Reserves

49,095,000

72,801,000

66,781,000

62,123,000

50,858,000

LIQUIDITY (Times)

Cash Ratio

0.01

0.00

0.01

0.01

0.04

Liquid Ratio

0.79

1.53

1.56

2.06

1.21

Current Ratio

1.33

2.24

2.44

3.10

1.95

WORKING CAPITAL CONTROL (Days)

Stock Ratio

147

108

130

95

93

Debtors Ratio

177

204

200

167

135

Creditors Ratio

17

42

35

32

20

SOLVENCY RATIOS (Times)

Gearing Ratio

0.46

0.16

0.15

0.20

0.04

Liabilities Ratio

0.99

0.50

0.49

0.35

0.65

Times Interest Earned Ratio

(10.60)

8.54

10.59

27.91

13.65

Assets Backing Ratio

7.14

10.26

9.49

8.93

7.37

PERFORMANCE RATIO (%)

Operating Profit Margin

(32.26)

9.22

8.48

18.43

14.96

Net Profit Margin

(29.99)

7.33

6.94

13.87

11.61

Return On Net Assets

(39.43)

11.83

10.70

24.80

29.84

Return On Capital Employed

(27.05)

10.19

9.29

21.19

29.80

Return On Shareholders' Funds/Equity

(40.12)

8.44

8.05

18.35

21.50

Dividend Pay Out Ratio (Times)

0.03

0.12

0.23

0.12

0.08

NOTES TO ACCOUNTS

Contingent Liabilities

0

0

0

0

0

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.62.39

UK Pound

1

Rs.94.16

Euro

1

Rs.73.61

 

INFORMATION DETAILS

 

Analysis Done by :

DIV

 

 

Report Prepared by :

DPT

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.